| Financial Year |
March 31 2023 |
| Monetary Funds |
2,449,474,790.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
47,429,329.62 |
| Accounts Receivable |
705,309,585.41 |
| Advances to Suppliers |
182,134,986.71 |
| Other Receivables |
34,910,275.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,653,575,715.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
121,103,908.48 |
| Total Current Assets |
6,349,923,577.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,514,009,932.25 |
| Under-construction Projects |
285,829,790.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
288,596,140.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
138,981,920.75 |
| Other Non-Current Assets |
166,289,313.48 |
| Sub-Total of Non-Current Assets |
2,396,451,391.27 |
| Total Assets |
8,746,374,969.15 |
| Short-Term Loans |
500,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
50,000,000.00 |
| Accounts Payable |
654,624,155.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
225,969,974.91 |
| Taxes Payable |
25,001,808.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
169,167,351.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
773,083.88 |
| Other Current Liabilities |
580,455,402.90 |
| Sub-Total of Current Liabilities |
4,410,601,372.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,682,681.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,476,513.68 |
| Total Liabilities |
4,502,077,886.60 |
| Paid-In Capital(Or Share Stock) |
576,682,400.00 |
| Capital Surplus |
1,377,216,904.01 |
| Surplus Reserve |
260,520,480.71 |
| LESS:Treasury Stock |
157,639,735.76 |
| Undistributed Profits |
2,147,287,986.92 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,244,297,082.55 |
| Owner's Equity（Stockholder's Equity） |
4,244,297,082.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,746,374,969.15 |
